Eckert & Ziegler BEBIG: Eckert & Ziegler buys Belgian provider of brachytherapy accessories
(Thomson Reuters ONE) -
Press Release
Regulated information
26 August 2016, 06:00 p.m.
Seneffe, August 26, 2016. Eckert & Ziegler BEBIG SA took over 100 % of the
shares in BrachySolutions BVBA effective August 26, 2016. The company, which is
based in Leuven, Belgium, is one of the largest independent European
distributors of prostate seeds. Its main markets are Benelux and Portugal. Both
parties have agreed not to disclose the purchase price.
Through the takeover, Eckert & Ziegler is acquiring BrachySolutions' customer
base in Benelux, the United Kingdom, and Portugal, thereby securing its strong
position in Europe as a manufacturer of seeds.
"By acquiring BrachySolutions, we are further honing our strategic focus. Our
strategy centers on consolidating the market, cementing our market position in
Europe, and creating synergies within our portfolio of solutions," said Dr.
Harald Hasselmann, Managing Director of Eckert & Ziegler BEBIG and member of the
Board of Directors.
"Eckert & Ziegler's Berlin-made prostate implants stand for top quality. I
believe firmly that our brachytherapy customers will continue to receive the
best possible products and excellent service in the future," Luk Herremans,
founder and Managing Director of BrachySolutions, added.
Brachytherapy is a medical treatment method that includes placing implants
containing radioisotopes directly into tumor tissue. The local radiation
provided by the implants leads to the destruction of cancer cells. Permanent
brachytherapy is mainly used to treat prostate cancer.
About Eckert & Ziegler BEBIG
Eckert & Ziegler BEBIG is a European-based group active in the medical device
segment of the health care industry. Its core business is the treatment of
cancer using brachytherapy, a special form of radiation therapy. Eckert &
Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters
are in Belgium, with a production facility in Germany and subsidiaries
throughout Europe, in the USA, India and Brazil. In addition, Eckert & Ziegler
BEBIG has a worldwide network of distributors and agents to support the
international marketing of its product line. The company's products and
equipment are intended for use by oncologists, radiologists, urologists and
medical physicists. Eckert & Ziegler BEBIG employs more than 120 people. The
company has been listed on the Euronext stock exchange since April 1997.
Contact:
Eckert & Ziegler BEBIG s.a.
Investor Relations
Tel.: +32 (0) 64 520 808
E-mail: ir(at)bebig.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 26.08.2016 - 18:00 Uhr
Sprache: Deutsch
News-ID 491347
Anzahl Zeichen: 3236
contact information:
Town:
Seneffe
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 371 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eckert & Ziegler BEBIG: Eckert & Ziegler buys Belgian provider of brachytherapy accessories"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert & Ziegler BEBIG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
